The present invention relates to novel compounds of formula (I) or a salt thereof: wherein R1 is a 5-membered heteroaryl group, optionally fused with a 6-membered hetero or carbocycle; such 5 or 11-membered system, may be optionally substituted by 1, 2, 3 or 4 substituents selected from the group consisting of: halogen, cyano, C1-4alkyl, haloC1-4alkyl, C1-4alkoxy, C1-4alkanoyl, haloC1-4alkoxy and SF5, and n is 1 or 2; processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as modulators of dopamine D3 receptors, e.g. to treat drug dependency, as antipsychotic agents, to treat obsessive compulsive spectrum disorders, or premature ejaculation.
本发明涉及式(I)的新化合物或其盐:其中R1是一个5-成员杂芳基团,可选地与一个6-成员杂环或碳环融合;这样的5或11-成员体系,可以选择地由卤素、
氰基、C1-4烷基、卤代C1-4烷基、C1-4烷氧基、C1-4烷酰基、卤代C1-4烷氧基和SF5中的1、2、3或4个取代基取代,并且n为1或2;其制备方法,用于这些方法的中间体,含有它们的药物组合物以及它们在治疗中的用途,作为
多巴胺D3受体调节剂,例如用于治疗药物依赖、作为
抗精神病药物、用于治疗强迫症谱系障碍或早泄。